rhil-21 (ProSpec)
ProSpec is a verified supplier 
ProSpec manufactures this product 
90
Structured Review
ProSpec
rhil-21
Rhil 21, supplied by ProSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-+21/rhil+21/pm22585684-154-36-37
Average 90 stars, based on 1 article reviews
Rhil 21, supplied by ProSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rhil-+21/rhil+21/pm22585684-154-36-37
Average 90 stars, based on 1 article reviews
rhil-21 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Cell Culture:Article Title: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma Article Snippet: Briefly, tumor tissue was cut into 1–2 mm 3 pieces with a sterile scalpel, washed twice with ice-cold PBS and cultured in 24-well plates in T-cell medium (Cellgro GMP-grade serum-free medium; CellGenix, Catalogue Number: 20801-0500) with 5% pooled human AB serum (Innovative Research, Catalogue Number: IPLA-SERAB-14668), supplemented with recombinant Article Title: Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Article Snippet: Where indicated (Fig. 4), (co-)cultures were done in the presence of the following cytokine concentrations: 50 IU/mL rhIL-2, 20 ng/mL rhIL-15, 2.5 ng/mL rhIL-12 (Peprotech, London, UK), 100 ng/mL rhIL-18 (MBL, NakaKu, Nagoya, Japan), 25 ng/mL Recombinant:Article Title: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma Article Snippet: Briefly, tumor tissue was cut into 1–2 mm 3 pieces with a sterile scalpel, washed twice with ice-cold PBS and cultured in 24-well plates in T-cell medium (Cellgro GMP-grade serum-free medium; CellGenix, Catalogue Number: 20801-0500) with 5% pooled human AB serum (Innovative Research, Catalogue Number: IPLA-SERAB-14668), supplemented with recombinant Article Title: Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Article Snippet: Where indicated (Fig. 4), (co-)cultures were done in the presence of the following cytokine concentrations: 50 IU/mL rhIL-2, 20 ng/mL rhIL-15, 2.5 ng/mL rhIL-12 (Peprotech, London, UK), 100 ng/mL rhIL-18 (MBL, NakaKu, Nagoya, Japan), 25 ng/mL Functional Assay:Article Title: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma Article Snippet: Briefly, tumor tissue was cut into 1–2 mm 3 pieces with a sterile scalpel, washed twice with ice-cold PBS and cultured in 24-well plates in T-cell medium (Cellgro GMP-grade serum-free medium; CellGenix, Catalogue Number: 20801-0500) with 5% pooled human AB serum (Innovative Research, Catalogue Number: IPLA-SERAB-14668), supplemented with recombinant Article Title: Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Article Snippet: Where indicated (Fig. 4), (co-)cultures were done in the presence of the following cytokine concentrations: 50 IU/mL rhIL-2, 20 ng/mL rhIL-15, 2.5 ng/mL rhIL-12 (Peprotech, London, UK), 100 ng/mL rhIL-18 (MBL, NakaKu, Nagoya, Japan), 25 ng/mL Produced:Article Title: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma Article Snippet: Briefly, tumor tissue was cut into 1–2 mm 3 pieces with a sterile scalpel, washed twice with ice-cold PBS and cultured in 24-well plates in T-cell medium (Cellgro GMP-grade serum-free medium; CellGenix, Catalogue Number: 20801-0500) with 5% pooled human AB serum (Innovative Research, Catalogue Number: IPLA-SERAB-14668), supplemented with recombinant Article Title: Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor. Article Snippet: Where indicated (Fig. 4), (co-)cultures were done in the presence of the following cytokine concentrations: 50 IU/mL rhIL-2, 20 ng/mL rhIL-15, 2.5 ng/mL rhIL-12 (Peprotech, London, UK), 100 ng/mL rhIL-18 (MBL, NakaKu, Nagoya, Japan), 25 ng/mL |